Legend Biotech Corp ADR (NASDAQ: LEGN) is -27.62% lower on its value in year-to-date trading and has touched a low of $38.60 and a high of $70.78 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The LEGN stock was last observed hovering at around $45.26 in the last trading session, with the day’s loss setting it -1.71%.
Currently trading at $43.55, the stock is -16.16% and -20.51% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.2 million and changing -3.78% at the moment leaves the stock -19.15% off its SMA200. LEGN registered -31.30% loss for a year compared to 6-month gain of -22.09%. The firm has a 50-day simple moving average (SMA 50) of $54.5406 and a 200-day simple moving average (SMA200) of $53.77545.
The stock witnessed a -23.10% loss in the last 1 month and extending the period to 3 months gives it a -2.99%, and is -12.74% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.65% over the week and 4.11% over the month.
Legend Biotech Corp ADR (LEGN) has around 1826 employees, a market worth around $7.98B and $455.99M in sales. Profit margin for the company is -62.50%. Distance from 52-week low is 12.82% and -38.47% from its 52-week high. The company has generated returns on investments over the last 12 months (-19.07%).
The EPS is expected to grow by 37.72% this year
The shares outstanding are 181.91M, and float is at 181.45M with Short Float at 5.77%.
The top institutional shareholder in the company is FMR LLC with over 17.62 million shares valued at $780.46 million. The investor’s holdings represent 9.6819 of the LEGN Shares outstanding. As of 2024-06-30, the second largest holder is PRICE T ROWE ASSOCIATES INC /MD/ with 11.49 million shares valued at $508.86 million to account for 6.3126 of the shares outstanding. The other top investors are RA CAPITAL MANAGEMENT, L.P. which holds 7.51 million shares representing 4.1246 and valued at over $332.48 million, while HHLR ADVISORS, LTD. holds 3.6463 of the shares totaling 6.64 million with a market value of $293.93 million.
Legend Biotech Corp ADR (LEGN) Insider Activity
Still, SEC filings show that on Sep 20 ’24, Yau Wai Man Philip (Director) Proposed Sale 1,946 shares at an average price of $51.04 for $99324.0. The insider now directly holds shares of Legend Biotech Corp ADR (LEGN).
